Figure 7.
Effect of SR 58611A and glibenclamide on basal blood glucose levels in lean and obese diabetic mice (n=4). *P<0.05, **P<0.005 compared to saline treated animals; •P<0.05, ••P<0.005 versus zero time.
Effect of SR 58611A and glibenclamide on basal blood glucose levels in lean and obese diabetic mice (n=4). *P<0.05, **P<0.005 compared to saline treated animals; •P<0.05, ••P<0.005 versus zero time.